• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol Gendered Effects on Inflammation Reaction and Outcome of COVID-19 Patients in Wuhan

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Jun 4.
doi: 10.1002/jmv.26137. Online ahead of print.
Gendered Effects on Inflammation Reaction and Outcome of COVID-19 Patients in Wuhan


Lu Qin[SUP] 1 2 [/SUP], Xiaochen Li[SUP] 1 2 [/SUP], Jing Shi[SUP] 1 2 [/SUP], Muqing Yu[SUP] 1 2 [/SUP], Ke Wang[SUP] 1 2 [/SUP], Yu Tao[SUP] 1 2 [/SUP], Ying Zhou[SUP] 1 2 [/SUP], Min Zhou[SUP] 1 2 [/SUP], Shuyun Xu[SUP] 1 2 [/SUP], Bo Wu[SUP] 3 [/SUP], Zhenyu Yang[SUP] 1 2 [/SUP], Cong Zhang[SUP] 1 2 [/SUP], Junqing Yue[SUP] 1 2 [/SUP], Chongsheng Cheng[SUP] 1 2 [/SUP], Xiansheng Liu[SUP] 1 2 [/SUP], Min Xie[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: The rapid outbreak of coronavirus disease 2019 (COVID-19) has turned into a public health emergency of international concern. Epidemiological research showed that gender was associated with the severity of COVID-19, but the underlying mechanism of gender predisposition remains poorly understood. We aim to study the gendered differences in inflammation reaction, and the association with severity and mortality of COVID-19.
Methods: In this retrospective study, we enrolled 548 COVID-19 inpatients from Tongji Hospital from January 26 to February 5, 2020, and followed up to March 3, 2020. Epidemiological, demographic and clinical features, and inflammatory indexes were collected and compared between males and females. Cox proportional hazard regression model was applied to identify gendered effect on mortality of COVID-19 after adjusting age, comorbidity and smoking history. Multiple linear regression method was used to explore the influence of sex on inflammation reaction.
Results: Males had higher mortality than females did (22.2% vs. 10.4%), with the HR of 1.923 (95% CI, 1.181-3.130); elder age and comorbidity were significantly associated with decease of COVID-19 patients. Excess inflammation reaction was related to severity of COVID-19. Male patients had greater inflammation reaction, with higher levels of IL-10, TNF-α, LDH, ferritin and hsCRP, but lower lymphocyte count than females adjusted by age and comorbidity.
Conclusions: Gender, age, and comorbidity are critical risk factors for mortality of COVID-19. Excess innate immunity and proinflammation activity, and deficiency in adaptive immunity response promote males especially elder males to develop cytokine storm, causing potential ARDS, multiple organ failure and decease. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; age; gender; inflammation; mortality.
 
Back
Top Bottom